Screener
Sotera Health SHC Sterigenics — Total net revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sotera Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Sotera Health’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001822479-26-000047
| (thousands of U.S. dollars) | Three Months Ended June 30, 2026 / Sterigenics | Three Months Ended June 30, 2026 / Nordion | Three Months Ended June 30, 2026 / Nelson Labs | Three Months Ended June 30, 2026 / Consolidated |
|---|---|---|---|---|
| Point in time | $211,571 | $47,232 | — | $258,803 |
| Over time | — | 1,917 | 60,655 | 62,572 |
| Total | $211,571 | $49,149 | $60,655 | $321,375 |
Item 1. Financial Statements.
FAQ
- What is Sotera Health's sterigenics — total net revenues?
- Sotera Health (SHC) reported sterigenics — total net revenues of $211.57M in Q2 2026.
- How has Sotera Health's sterigenics — total net revenues changed year-over-year?
- Sotera Health's sterigenics — total net revenues increased by 8.6% year-over-year, from $194.84M to $211.57M.
- What is the long-term trend for Sotera Health's sterigenics — total net revenues?
- Over 4 years (2021 to 2025), Sotera Health's sterigenics — total net revenues has grown at a 7.2% compound annual growth rate (CAGR), from $571.83M to $755.78M.
- What does sterigenics — total net revenues mean?
- Represents the total gross revenue generated by the Sterigenics segment after deducting returns, allowances, and discounts. This metric reflects the core market demand for outsourced terminal sterilization and irradiation services provided to medical device and pharmaceutical clients.
Ask your AI about Sotera Health's sterigenics — total net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude